Drug intelligence / Profile preview

Bioflan

Development stage
Unknown
Lead developer
Myralis
Modality
Small Molecules
Administration
Oral
01

Overview

Bioflan is a phytotherapeutic (herbal) anti-inflammatory and analgesic medication developed and manufactured by the Brazilian pharmaceutical company Myralis. The product contains a standardized extract of *Harpagophytum procumbens* (Devil's Claw), with each tablet providing 250mg of the extract standardized to contain 30mg of harpagoside. Formulated as gastro-resistant coated tablets to protect the active ingredients from gastric acid, Bioflan is indicated for the symptomatic relief of moderate joint pain and acute lower back pain. It is commonly used to treat various rheumatic conditions, including arthritis, osteoarthritis, bursitis, and tendinitis. Bioflan is available as an over-the-counter (OTC) medication in Brazil and is distributed widely across the country.

Brand names
Bioflan
Other names
Harpagophytum procumbens extractDevil's Claw extract
02

Targets

FOS (Activator Protein 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on Bioflan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioflan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call